Synthesis, characterization and in vitro hydrolysis of a gemfibrozil-nicotinic acid codrug for improvement of lipid profile
作者:Amjad M. Qandil、Meriem M. Rezigue、Bassam M. Tashtoush
DOI:10.1016/j.ejps.2011.03.012
日期:2011.6
therapy of fibrates and nicotinic acid has been reported to be synergistic. Herein, we describe a covalent codrug of gemfibrozil (GEM) and nicotinic acid (NA) that was synthesized and characterized by 1H NMR, 13C NMR, FT-IR, MS analysis and elemental analysis. A validated HPLC method was developed that allows for the accurate quantitative determination of the codrug and its hydrolytic products that
据报道,贝特类药物和烟酸的联合治疗具有协同作用。在这里,我们描述了吉非贝齐(GEM)和烟酸(NA)的共价共价药物,该药物通过1 H NMR合成并表征,1313 C NMR,FT-IR,MS分析和元素分析。开发了一种经过验证的HPLC方法,可以准确定量测定在体外化学水解和酶促水解过程中形成的共同药物及其水解产物。相较于其母体药物,在水溶性和分配系数方面,共同药物的理化性质得到了改善。在高温下于pH 1.2、6.8和7.4的磷酸盐缓冲水溶液中使用加速水解实验研究了共药的水解动力学。使用Arrhenius方程,在37°C时外推的半衰期在cod的pH值为1.2时为289天,在codrug和吉非贝齐2-羟乙基酯(GHEE)的pH值为6.8时分别为130和20,315天。最短的半衰期是在pH 7.4上。共同用药42天,GHEE 5837天。仅在80°C和pH 1.2下研究了后者的水解,并将其与在相似条